Scientists track MS Drug's path to breast milk
NCT ID NCT06143514
Summary
This study aims to measure how much of the multiple sclerosis medication BRIUMVI passes into breast milk when breastfeeding mothers take it. Researchers will collect milk samples from 16 participants over 24 hours after their dose to track the drug's levels. The goal is to gather safety information to help guide breastfeeding recommendations for mothers being treated for MS.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
PROVIDE Virtual Research Coordination Center
RECRUITINGSan Francisco, California, 94158, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
PROVIDE Virtual Research Coordination Center
RECRUITINGSmyrna, Georgia, 30080, United States
-
PROVIDE Virtual Research Coordination Center
RECRUITINGWilmington, North Carolina, 28401-3331, United States
-
PROVIDE Virtual Research Coordination Center
RECRUITINGNashville, Tennessee, 37215, United States
Conditions
Explore the condition pages connected to this study.